Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
APOGOSSYPOL
ID: ALA551288
Max Phase: Preclinical
Molecular Formula: C28H30O6
Molecular Weight: 462.54
Molecule Type: Small molecule
Associated Items:
ID: ALA551288
Max Phase: Preclinical
Molecular Formula: C28H30O6
Molecular Weight: 462.54
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: Cc1cc2c(C(C)C)c(O)c(O)cc2c(O)c1-c1c(C)cc2c(C(C)C)c(O)c(O)cc2c1O
Standard InChI: InChI=1S/C28H30O6/c1-11(2)21-15-7-13(5)23(25(31)17(15)9-19(29)27(21)33)24-14(6)8-16-18(26(24)32)10-20(30)28(34)22(16)12(3)4/h7-12,29-34H,1-6H3
Standard InChI Key: PBJKWGWHZVXBGU-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 462.54 | Molecular Weight (Monoisotopic): 462.2042 | AlogP: 6.76 | #Rotatable Bonds: 3 |
Polar Surface Area: 121.38 | Molecular Species: NEUTRAL | HBA: 6 | HBD: 6 |
#RO5 Violations: 2 | HBA (Lipinski): 6 | HBD (Lipinski): 6 | #RO5 Violations (Lipinski): 2 |
CX Acidic pKa: 8.68 | CX Basic pKa: | CX LogP: 7.29 | CX LogD: 7.27 |
Aromatic Rings: 4 | Heavy Atoms: 34 | QED Weighted: 0.19 | Np Likeness Score: 0.72 |
1. Wei J, Kitada S, Rega MF, Stebbins JL, Zhai D, Cellitti J, Yuan H, Emdadi A, Dahl R, Zhang Z, Yang L, Reed JC, Pellecchia M.. (2009) Apogossypol derivatives as pan-active inhibitors of antiapoptotic B-cell lymphoma/leukemia-2 (Bcl-2) family proteins., 52 (14): [PMID:19555126] [10.1021/jm900472s] |
2. Zhang L, Jiang H, Cao X, Zhao H, Wang F, Cui Y, Jiang B.. (2009) Chiral gossypol derivatives: evaluation of their anticancer activity and molecular modeling., 44 (10): [PMID:19447525] [10.1016/j.ejmech.2009.04.025] |
3. Zhang L, Jiang H, Cao X, Zhao H, Wang F, Cui Y, Jiang B.. (2009) Chiral gossypol derivatives: evaluation of their anticancer activity and molecular modeling., 44 (10): [PMID:19447525] [10.1016/j.ejmech.2009.04.025] |
4. (2015) Naphthalene-based inhibitors of anti-apoptotic proteins, |
5. Nhu D, Lessene G, Huang DCS, Burns CJ. (2016) Small molecules targeting Mcl-1: the search for a silver bullet in cancer therapy, 7 (5): [10.1039/C5MD00582E] |
6. Yang S, Mao Y, Zhang H, Xu Y, An J, Huang Z.. (2019) The chemical biology of apoptosis: Revisited after 17 years., 177 [PMID:31129454] [10.1016/j.ejmech.2019.05.019] |
7. Gampe C, Verma VA.. (2020) Curse or Cure? A Perspective on the Developability of Aldehydes as Active Pharmaceutical Ingredients., 63 (23.0): [PMID:32916044] [10.1021/acs.jmedchem.0c01177] |
8. Liu T, Wu Z, He Y, Xiao Y, Xia C.. (2020) Single and dual target inhibitors based on Bcl-2: Promising anti-tumor agents for cancer therapy., 201 [PMID:32563811] [10.1016/j.ejmech.2020.112446] |
Source(2):